Browsing Tag
Zepbound tirzepatide
1 post
Eli Lilly ($LLY) surges past $1.07tn as EU oncology win and Medicare GLP-1 program align with analyst upgrade
Eli Lilly NYSE LLY surges 6.3 percent to record $1,208.12 on EU Jaypirca approval, Medicare GLP-1 Bridge Program and Leerink price target raise. Read more.